Proteomic mapping of bezafibrate-treated human hepatocytes in primary culture using two-dimensional liquid chromatography

Toxicology Letters

Volumn 201, Issue 2, 2011, Pages 123-129

  Alvergnas, M ^a,b   Rouleau, A ^b   Lucchi, G ^b   Heyd, B ^c   Ducoroy, P ^b   Richert, L ^a,d   Martin, H ^a,b  

^a France   (France)

^b Besançon Dijon ^*  (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^d KaLy Cell   (France)

Author keywords

Bezafibrate; Fractionation; Human hepatocytes; N Acetylcysteine; PF2D; Proteomic map

Indexed keywords

ACETYLCYSTEINE; BEZAFIBRATE; LIVER PROTEIN; MEMBRANE PROTEIN;

ADULT; AGED; ARTICLE; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; LIVER CELL; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLISM; PEROXISOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SWISS-PROT;

ACETYLCYSTEINE; BEZAFIBRATE; CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; HEPATOCYTES; HUMANS; OXIDATION-REDUCTION; PROTEOMICS;

RODENTIA;

EID: 79651470657     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.12.015     Document Type: Article

References (46)

1. Alvergnas M., Richert L., Blanchard N., Abadie C., Heyd B., Mantion G., Gallemann D., Martin H. Regulation of CYP4A expression by bezafibrate in primary culture of rat and human hepatocytes: interspecies difference and influence of N-acetylcysteine. Toxicol. In Vitro 2009, 23:1259-1267.
2. Bandara L.R., Kennedy S. Toxicoproteomics-a new preclinical tool. Drug Discov. Today 2002, 7:411-418.
3. Bars R.G., Bell D.R., Elcombe C.R. Induction of cytochrome P450 and peroxisomal enzymes by clofibric acid in vivo and in vitro. Biochem. Pharmacol. 1993, 45:2045-2053.
4. Beckhove P., Warta R., Lemke B., Stoycheva D., Momburg F., Schnölzer M., Warnken U., Schmitz-Winnenthal H., Ahmadi R., Dyckhoff G., Bucur M., Jünger S., Schueler T., Lennerz V., Woelfel T., Unterberg A., Herold-Mende C. Rapid T cell-based identification of human tumor tissue antigens by automated two-dimensional protein fractionation. J. Clin. Invest. 2010, 120:2230-2242.
5. Billecke C., Malik I., Movsisyan A., Sulghani S., Sharif A., Mikkelsen T., Farrell N.P., Bögler O. Analysis of glioma cell platinum response by metacomparison of two-dimensional chromatographic proteome profiles. Mol. Cell. Proteomics 2006, 5:35-42.
6. Blaauboer B.J., van Holsteijn C.W., Bleumink R., Mennes W.C., van Pelt F.N., Yap S.H., van Pelt J.F., van Iersel A.A., Timmerman A., Schmid B.P. The effect of beclobric acid and clofibric acid on peroxisomal beta-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes. Biochem. Pharmacol. 1990, 40:521-528.
7. Cherkaoui-Malki M., Meyer K., Cao W.Q., Latruffe N., Yeldandi A.V., Rao M.S., Bradfield C.A., Reddy J.K. Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis. Gene Expr. 2001, 9:291-304.
8. Chu R., Lim H., Brumfield L., Liu H., Herring C., Ulintz P., Reddy J.K., Davison M. Protein profiling of mouse livers with peroxisome proliferator-activated receptor alpha activation. Mol. Cell. Biol. 2004, 24:6288-6297.
9. David R.M., Moore M.R., Cifone M.A., Finney D.C., Guest D. Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery. Toxicol. Sci. 1999, 50:195-205.
10. De La Iglesia F.A., Lewis J.E., Buchanan R.A., Marcus E.L., McMahon G. Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment. Atherosclerosis 1982, 43:19-37.
11. Elcombe C.R., Mitchell A.M. Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms. Environ. Health Perspect. 1986, 70:211-219.
12. Fountoulakis M., Suter L. Proteomic analysis of the rat liver. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002, 782:197-218.
13. Galeva N., Altermann M. Comparison of one-dimensional and two-dimensional gel electrophoresis as a separation tool for proteomic analysis of rat liver microsomes: cytochromes P450 and other membrane proteins. Proteomics 2002, 2:713-722.
14. Garbis S., Lubec G., Fountoulakis M. Limitations of current proteomics technologies. J. Chromatogr. A 2005, 1077:1-18.
15. Goll V., Alexandre E., Viollon-Abadie C., Nicod L., Jaeck D., Richert L. Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities DNA synthesis, and apoptosis in rat and human hepatocyte cultures. Toxicol. Appl. Pharmacol. 1999, 160:21-32.
16. Goll V., Viollon-Abadie C., Nicod L., Richert L. Peroxisome proliferators induce apoptosis and decrease DNA synthesis in hepatoma cell lines. Hum. Exp. Toxicol. 2000, 19:193-202.
17. Guo W.X., Man X.B., Yuan H.X., Shi J., Xue J., Wu M.C., Cheng S.Q. Proteomic analysis on portal vein tumor thrombus-associated proteins for hepatocellular carcinoma. Zhonghua Yi Xue Za Zhi 2007, 87:2094-2097.
18. Hispard, F., de Vaufleury, A., Schaeffer, C., Scheifler, R., Badot, P.-M., Richert, L., Martin, H., in press. Differential liver proteome mapping of control and cadmium-fed rats. Ecotoxicol. Environ. Saf. doi:10.1016/j.ecoenv.2010.07.038.
19. Huang H., Starodub O., McIntosh A., Kier A.B., Schroeder F. Liver fatty acid-binding protein targets fatty acids to the nucleus DNA synthesis, and apoptosis in rat and human hepatocyte cultures. J. Biol. Chem. 2002, 277:29139-29151.
20. Huttunen J.K., Heinonen O.P., Manninen V., Koskinen P., Hakulinen T., Teppo L., Mänttäri M., Frick M.H. The Helsinki heart study: an 8.5 year safety and mortality follow-up. J. Intern. Med. 1994, 235:31-39.
21. Jiang X.S., Zhou H., Zhang L., Sheng Q.H., Li S.J., Li L., Hao P., Li Y.X., Xia Q.C., Wu J.R., Zeng R. A high-throughput approach for subcellular proteome: identification of rat liver proteins using subcellular fractionation coupled with two-dimensional liquid chromatography tandem mass spectrometry and bioinformatic analysis. Mol. Cell. Proteomics 2004, 3:441-455.
22. Kawase H., Fujii K., Miyamoto M., Kubota K.C., Hirano S., Kondo S., Inagaki F. Differential LC-MS-based proteomics of surgical human cholangiocarcinoma tissues. J. Proteome Res. 2009, 8:4092-4103.
23. Kim R.H., Peters M., Jang Y., Shi W., Pintilie M., Fletcher G.C., DeLuca C., Liepa J., Zhou L., Snow B., Binari R.C., Manoukian A.S., Bray M.R., Liu F.F., Tsao M.S., Mak T.W. DJ-1; a novel regulator of the tumor suppressor PTEN. Cancer Cell 2005, 7:263-273.
24. Lake B.G. Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis. Toxicol. Lett. 1995, 82-83:673-681.
25. Lake B.G., Rumsby P.C., Price R.J., Cunninghame M.E. Species differences in hepatic peroxisome proliferation, cell replication and transforming growth factor-beta1 gene expression in the rat, Syrian hamster and guinea pig. Mutat. Res. 2000, 448:213-225.
26. Lee H.C., Tian B., Sedivy J.M., Wands J.R., Kim M. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology 2006, 131:1208-1217.
27. Lee H.J., Kang M.J., Lee E.Y., Cho S.Y., Kim H., Paik Y.K. Application of a peptide-based PF2D platform for quantitative proteomics in disease biomarker discovery. Proteomics 2008, 8:3371-3381.
28. Lee H.J., Kwon M.S., Lee E.Y., Cho S.Y., Paik Y.K. Establishment of a PF2D-MS/MS platform for rapid profiling and semiquantitative analysis of membrane protein biomarkers. Proteomics 2008, 8:2168-2177.
29. Léonard J.F., Courcol M., Mariet C., Charbonnier A., Boitier E., Duchesne M., Parker F., Genet B., Supatto F., Roberts R., Gautier J.C. Proteomic characterization of the effects of clofibrate on protein expression in rat liver. Proteomics 2006, 6:1915-1933.
30. Levreri I., Musante L., Petretto A., Bruschi M., Candiano G., Melioli G. Separation of human serum proteins using the Beckman-Coulter PF2D system: analysis of ion exchange-based first dimension chromatography. Clin. Chem. Lab. Med. 2005, 43:1327-1333.
31. Linke T., Ross A.C., Harrison E.H. Proteomic analysis of rat plasma by two-dimensional liquid chromatography and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. J. Chromatogr. A 2006, 1123:160-169.
32. Lubman D.M., Kachman M.T., Wang H., Gong S., Yan F., Hamler R.L., O'Neil K.A., Zhu K., Buchanan N.S., Barder T.J. Two-dimensional liquid separations-mass mapping of proteins from human cancer cell lysates. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002, 782:183-196.
33. Martin H., Staedtler F., Lamboley C., Adrian M., Schumacher M.M., Chibout S.D., Laurant P., Richert L., Berthelot A. Effects of long-term dietary intake of magnesium on rat liver transcriptome. Magnes. Res. 2007, 20:259-265.
34. Németh J., Stein I., Haag D., Riehl A., Longerich T., Horwitz E., Breuhahn K., Gebhardt C., Schirmacher P., Hahn M., Ben-Neriah Y., Pikarsky E., Angel P., Hess J. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology 2009, 50:1251-1262.
35. Richert L., Alexandre E., Lloyd T., Orr S., Viollon-Abadie C., Patel R., Kingston S., Berry D., Dennison A., Heyd B., Mantion G., Jaeck D. Tissue collection, transport and isolation procedures required to optimize human hepatocytes isolation from waste liver surgical resections. A multilaboratory study. Liver Int. 2004, 24:371-378.
36. Richert L., Lamboley C., Viollon-Abadie C., Grass P., Hartmann N., Laurent S., Heyd B., Mantion G., Chibout S.D., Staedtler F. Effects of clofibric acid on mRNA expression profiles in primary cultures of rat, mouse and human hepatocytes. Toxicol. Appl. Pharmacol. 2003, 191:130-146.
37. Richert L., Price S., Chesne C., Maita K., Carmichael N. Comparison of the induction of hepatic peroxisome proliferation by the herbicide oxadiazon in vivo in rats, mice, and dogs and in vitro in rat and human hepatocytes. Toxicol. Appl. Pharmacol. 1996, 141:35-43.
38. Roberts R.A., Soames A.R., Gill J.H., James N.H., Wheeldon E.B. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis 1995, 16:1693-1698.
39. Sheng S., Chen D., Van Eyk J.E. Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: optimization and protein database. Mol. Cell. Proteomics 2006, 5:26-34.
40. Shin Y.K., Lee H.J., Lee J.S., Paik Y.K. Proteomic analysis of mammalian basic proteins by liquid-based two-dimensional column chromatography. Proteomics 2006, 6:1143-1150.
41. Siegers C.P., Bossen K.H., Younes M., Mahlke R., Oltmanns D. Glutathione and glutathione-S-transferases in the normal and diseased human liver. Pharmacol. Res. Commun. 1982, 14:61-72.
42. Singleton D.W., Lei X.D., Webb S.J., Prough R.A., Geoghegan T.E. Cytochrome P-450 mRNAs are modulated by dehydroepiandrosterone, nafenopin, and triiodothyronine. Drug Metab. Dispos. 1999, 27:193-200.
43. Skalnikova H., Halada P., Dzubak P., Hajduch M., Kovarova H. Protein fingerprints of anti-cancer effects of cyclin-dependent kinase inhibition: identification of candidate biomarkers using 2-D liquid phase separation coupled to mass spectrometry. Technol. Cancer Res. Treat. 2005, 4:447-454.
44. Song I.S., Kim S.U., Oh N.S., Kim J., Yu D.Y., Huang S.M., Kim J.M., Lee D.S., Kim N.S. Peroxiredoxin I contributes to TRAIL resistance through suppression of redox-sensitive caspase activation in human hepatoma cells. Carcinogenesis 2009, 30:1106-1114.
45. White I.R., Man W.J., Bryant D., Bugelski P., Camilleri P., Cutler P., Hayes W., Holbrook J.D., Kramer K., Lord P.G., Wood J. Protein expression changes in the Sprague Dawley rat liver proteome following administration of peroxisome proliferator activated receptor alpha and gamma ligands. Proteomics 2003, 3:505-512.
46. Wolfrum C., Borrmann C.M., Borchers T., Spener F. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha- and gamma- mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:2323-2328.